ClinicalTrials.Veeva

Menu
N

North Hills Medical Research Inc | North Richland Hills, TX

Research site

Site insights

Top conditions

Top treatments

LY3298176
Tirzepatide
Orforglipron
Dapagliflozin
amlodipine
LY3502970
Bococizumab
BMS-512148
indapamide
CIN-102

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

ted melliza

Verified by this site

Active trials

10 of 29 total trials
New

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

This is a 26-week, multi-center, randomized, double-blind, placebo-controlled study with a 4-week treatment-free Safety Follow-up period to assess th...

Enrolling
Chronic Idiopathic Constipation (CIC)
Drug: Tenapanor 50 mg BID
Drug: Tenapanor 5 mg BID

The GZPL master protocol will support 2 independent studies, J2A-MC-GZL1 (GZL1) and J2A-MC-GZL2 (GZL2). The purpose of this study is to create a fram...

Enrolling
Hypertension
Drug: Orforglipron
Drug: Placebo

GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hy...

Enrolling
Hypertension
Overweight or Obesity
Drug: Placebo
Drug: Orforglipron

GZL2 is an independent study conducted under the GZPL master protocol. GZL2 study will evaluate the efficacy and safety of orforglipron for treatment...

Enrolling
Hypertension
Drug: Orforglipron
Drug: Placebo

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the...

Active, not recruiting
Crohn's Disease
Drug: Placebo for risankizumab
Drug: Risankizumab SC

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopa...

Active, not recruiting
Idiopathic Gastroparesis
Drug: Placebo
Drug: CIN-102 Dose 15mg

The purpose of this study is to evaluate the blood pressure (BP)-lowering efficacy of tonlamarsen in adult participants who, despite taking 2 or more...

Active, not recruiting
Hypertension
Drug: Tonlamarsen
Drug: Placebo

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Obicetrapib
Drug: Placebo

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of car...

Enrolling
Overweight
Atherosclerotic Cardiovascular Disease
Drug: Maridebart Cafraglutide
Drug: Placebo

Trial sponsors

Lilly logo
AstraZeneca logo
G
Pfizer logo
AbbVie logo
Amgen logo
Ardelyx logo
C
K
Mass General Brigham logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems